FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $7,754,000 | +32.4% | 200,000 | 0.0% | 0.64% | -11.4% |
| Q4 2021 | $5,856,851 | -1.3% | 200,000 | 0.0% | 0.72% | -12.1% |
| Q3 2021 | $5,932,927 | -31.7% | 200,000 | 0.0% | 0.82% | -33.3% |
| Q2 2021 | $8,687,679 | +5.3% | 200,000 | 0.0% | 1.24% | -4.2% |
| Q1 2021 | $8,253,245 | -9.3% | 200,000 | 0.0% | 1.29% | -10.9% |
| Q4 2020 | $9,102,093 | – | 200,000 | – | 1.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |